Where does Immunovative Therapies, Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Immunovative Therapies, Ltd. ranks #21,263 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Immunovative Therapies, Ltd. hold?

Immunovative Therapies, Ltd. holds 13 US utility patents granted between 2016 and 2019, spanning 10 technology areas.

What is Immunovative Therapies, Ltd.'s Innovation Score?

Immunovative Therapies, Ltd. has an Innovation Score of 25.0 out of 100 (16th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Immunovative Therapies, Ltd. focus on?

Immunovative Therapies, Ltd.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 12 patents, ranking #1,877 of 7,163 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Immunovative Therapies, Ltd.'s patent grant rate increasing or decreasing?

Immunovative Therapies, Ltd.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Immunovative Therapies, Ltd.'s patents?

Immunovative Therapies, Ltd.'s patents average 7.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Immunovative Therapies, Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Immunovative Therapies, Ltd.

USPTO PatentsView assignee record - 13 granted patents across 10 technology areas, recorded in grant years 2016–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Immunovative ranks #21,263 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 10 technology areas.

#21,263
of 49,997 US assignees by volume: 16th percentile
by Innovation Score (25.0/100): 7.8
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21263 · Foreign Corporation #21,263 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #21,263/49,997
PHOTO-FINISH IEI Integration
CPC-FOCUS A61K · 10 areas
INNOV-THIN 25.0/100
CLAIMS-SPARSE 7.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: IEI Integration Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Immunovative’s 25.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (36%) Velocity 0.0 pts (0%) Breadth 11.2 pts (45%) Claim depth 4.7 pts (19%)

Qualcomm Incorporated · highest

85
Immunovative Therapies · this assignee

25
3D Lighting… · lowest

7

What this shows Immunovative's Innovation Score is 25.0/100 (16th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Immunovative?

Each dot is one of Immunovative’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Immunovative’s own 7.8 claims/patent is at or below the 9.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Immunovative vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Immunovative's grants concentrate

Immunovative Therapies, Ltd. is a focused PatentsView assignee: 10 CPC subclasses with 92.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (6 grants) versus a trough of 3 in 2017. By volume, Immunovative sits between IEI Integration Corp. and Innovaquartz LLC.

IEI Integration

13
Iflytek

13
IHI Inspection AN…

13
III Holdings 6

13
Inducomp

13
Industriale Chimi…

13
Infosys

13
Innovaquartz

13
Immunovative Ther… ◀

13

What this shows Immunovative holds 13 patents at rank #21,256, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Immunovative

By rank, the assignees closest to #21,256 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Immunovative's primary technology class.

Immunovative's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 16th percentile higher than 16% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Immunovative Therapies, Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	6	46.2%
2017	3	23.1%
2019	4	30.8%

Which technologies does Immunovative Therapies, Ltd. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 12

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 11

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 8

Y02A - Technologies FOR Adaptation TO Climate Change 3

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

G07F - Coin-freed OR Like Apparatus 1

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 1

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 1

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Immunovative Therapies, Ltd.'s patent record in context - here's where to go next.

Immunovative Therapies, Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 92.3% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #21,263 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Immunovative Therapies, Ltd. against IEI Integration Corp., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.